- Home
- BRTX vs APTO Comparison
BRTX vs APTO Comparison
Compare BRTX & APTO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BRTX
- APTO
- Stock Information
- Founded
- BRTX 1997
- APTO 1986
- Country
- BRTX United States
- APTO Canada
- Employees
- BRTX N/A
- APTO N/A
- Industry
- BRTX Managed Health Care
- APTO Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- BRTX Health Care
- APTO Health Care
- Exchange
- BRTX Nasdaq
- APTO Nasdaq
- Market Cap
- BRTX 11.3M
- APTO 11.5M
- IPO Year
- BRTX N/A
- APTO N/A
- Fundamental
- Price
- BRTX $1.41
- APTO $0.18
- Analyst Decision
- BRTX Strong Buy
- APTO Strong Buy
- Analyst Count
- BRTX 1
- APTO 3
- Target Price
- BRTX $18.00
- APTO $4.33
- AVG Volume (30 Days)
- BRTX 100.5K
- APTO 1.4M
- Earning Date
- BRTX 11-12-2024
- APTO 11-08-2024
- Dividend Yield
- BRTX N/A
- APTO N/A
- EPS Growth
- BRTX N/A
- APTO N/A
- EPS
- BRTX N/A
- APTO N/A
- Revenue
- BRTX $377,000.00
- APTO N/A
- Revenue This Year
- BRTX $482.76
- APTO N/A
- Revenue Next Year
- BRTX $212.24
- APTO N/A
- P/E Ratio
- BRTX N/A
- APTO N/A
- Revenue Growth
- BRTX 189.55
- APTO N/A
- 52 Week Low
- BRTX $1.03
- APTO $0.13
- 52 Week High
- BRTX $3.67
- APTO $2.68
- Technical
- Relative Strength Index (RSI)
- BRTX 41.13
- APTO 29.73
- Support Level
- BRTX $1.40
- APTO $0.18
- Resistance Level
- BRTX $1.60
- APTO $0.22
- Average True Range (ATR)
- BRTX 0.10
- APTO 0.01
- MACD
- BRTX 0.00
- APTO 0.01
- Stochastic Oscillator
- BRTX 42.86
- APTO 22.50
About BRTX BioRestorative Therapies Inc. (NV)
BioRestorative Therapies Inc is a biotechnology company based in the United States. It focuses on the development of regenerative medicine products and therapies using cell and tissue protocols, primarily involving adult (non-embryonic) stem cells. The company's two core development programs include the Disc/Spine Program, which involves cell therapy candidate, BRTX-100, a product formulated from autologous cultured mesenchymal stem cells collected from the patient's bone marrow; and the Metabolic Program, which includes the development of cell-based therapy to target obesity and metabolic disorders using brown adipose-derived stem cells, to generate brown adipose tissue.
About APTO Aptose Biosciences Inc.
Aptose Biosciences Inc is a clinical-stage biotechnology company committed to discovering and developing personalized therapies addressing unmet medical needs in oncology. The Company's small molecule cancer therapeutics pipeline includes products designed to provide single agent efficacy and to enhance the efficacy of other anti-cancer therapies and regimens without overlapping toxicities.